Literature DB >> 17377607

Use of neostigmine to relieve a suspected colonic pseudoobstruction in pregnancy.

M E Rausch1, N H Troiano, T Rosen.   

Abstract

Neostigmine is a treatment option for colonic pseudoobstruction. However, experience in using neostigmine for this indication in pregnant women is limited. We present a case of a woman with an estimated fetal gestational age of 34 weeks presented with what was believed to be a pseudoobstruction and when conservative management failed, neostigmine was administered with no adverse side effects. Ultimately, the patient was found to have a mechanical obstruction and we discuss the challenges in making this diagnosis in pregnancy. Neostigmine may be a viable alternative to colonoscopy in pregnant women for whom mechanical obstruction is properly excluded.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17377607     DOI: 10.1038/sj.jp.7211669

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  4 in total

Review 1.  Risks versus benefits of gastrointestinal endoscopy during pregnancy.

Authors:  Mitchell S Cappell
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-04       Impact factor: 46.802

Review 2.  Gastrointestinal endoscopy in pregnancy.

Authors:  Nurten Savas
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

3.  Challenges in management of gastrointestinal cancers in pregnancies: A report of three cases.

Authors:  Serene Thain; Jess McMicking; Julien de Naurois; Catherine Nelson-Piercy
Journal:  Obstet Med       Date:  2021-03-09

Review 4.  Does lower gastrointestinal endoscopy during pregnancy pose a risk for mother and child? - a systematic review.

Authors:  Alison De Lima; Boris Galjart; Pieter H A Wisse; Wichor M Bramer; C Janneke van der Woude
Journal:  BMC Gastroenterol       Date:  2015-02-12       Impact factor: 3.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.